Sunday, December 17, 2017
Tailwinds' Take: the implications of this study are potentially massive. It truly appears that NR has many positive effects and is well on its way to becoming a blockbuster supplement. No side effects, many benefits. There appears to be...
IRVINE, Calif., Dec. 08, 2017 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC), a science-based, fully integrated nutraceutical company devoted to extending human healthspan, announced today that in research published in the journal Nature, Dr. Johan Auwerx showed that Alzheimer’s disease...
I'm just going to lay it out there with the risk of being viewed as overly promotional: Nicotinamide Ribosome (otherwise known as Niagen) has produced some very positive, albeit early-stage, results as a potential cure for Alzheimer's. This is potentially...
ChromaDex (CDXC) reported earnings yesterday. As expected, they lost money during this period where they are investing in the development of Tru Niagen as a potential blockbuster supplement. Looking beyond the bottom line, which is basically irrelevant at this...
IRVINE, Calif., Nov. 09, 2017 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC), a science-based, fully integrated nutraceutical company devoted to extending human healthspan, announced today the financial results for the quarter ended September 30, 2017. Frank Jaksch, Jr., CEO and co-founder of ChromaDex commented, “The science continues to...
Yesterday Chromadex announced the pricing of a private placement for $23M dollars. This deal was significant to the Company in that they have padded their purse at a time when they are rolling out Tru Niagen on a global...
Tailwinds' Take: This financing was led by ICONIQ Capital, which is a Mark Zuckerberg led investment fund. All other investors (except one small one out of Singapore) are HK based. It appears the Watsons' rollout must be going well....
Tailwinds' Take: a great new hire for the Company, Farr has the experience to help build Tru Niagen into a global consumer brand. His leaving a large global business like Mattel to join CDXC demonstrates the upside potential here. IRVINE,...
Tailwinds' Take: very positive news for CDXC as this demonstrates the positive effects of Niagen in anti-aging activity. Expect more studies to continue showing efficacy and Niagen to become the next blockbuster supplement in the market. IRVINE, Calif., Sept. 26,...
As an investor in ChromaDex (CDXC), and a user of their lead product Tru Niagen, I'm a firm believer in the health benefits of Nicotinamide Riboside (NR). NR in its consumer form is more commonly known as Niagen, which is...
Follow

Follow this blog

Get every new post delivered right to your inbox.

Email address